No abstract

No abstract

No abstract

CIS-R and WHODAS 2.0). Excluding death, the utility values of the therapeutic areas most often modelled like infectious diseases, ophthalmology, endocrine disorders and oncology, ranged from 0-1, 0.18-0.99, 0.55-0.87 and 0.5-0.94, respectively. For the rest of the therapeutic areas, such as blood disorders, mental disorders, nephrology and neurology, utility values ranged from 0.61-0.93, 0.82-0.84, 0.39-0.71 and -0.495-0.9, respectively. Conclusions: This systematic review provides a set of published health state utility values of different therapeutic areas modelled in cost utility evaluations conducted from Indian perspective. It also provides an overview of the methods and the instruments employed to retrieve the utility values